Pacira Biosciences, Inc. (PCRX)
22.44
-0.20
(-0.88%)
USD |
NASDAQ |
May 18, 16:00
22.45
+0.01
(+0.04%)
After-Hours: 20:00
Pacira Biosciences Cash from Investing (Quarterly) : 19.44M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 4.542M |
| Bristol Myers Squibb Co. | -131.00M |
| Assertio Holdings, Inc. | 15.11M |
| Johnson & Johnson | -1.04B |
| Eli Lilly & Co. | -3.916B |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 25.68M |
| Cash from Financing (Quarterly) | -59.40M |
| Free Cash Flow | 132.71M |
| Free Cash Flow Per Share (Quarterly) | 0.5611 |
| Free Cash Flow to Equity (Quarterly) | 29.98M |
| Free Cash Flow to Firm (Quarterly) | 25.11M |
| Free Cash Flow Yield | 13.61% |